ICU sedation, delirium & recovery
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Recommendations
As issued by the authors
Recommendations for diagnosis, management and treatment of cytokine release syndrome, immune effector cell associated neurotoxicity syndrome, hematotoxicity, hypogammaglobulinemia and CAR-T cell-induced pseudo-progression, among others
Original publication
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities. Intensive Care Med. Published 22 August 2024. doi:10. 1007/ s00134-024-07576-4
Composed by AI from the published abstract and checked against it. How Briefs are made →